Skip to content

Posts by: Patrick Cox

Author Image for Patrick Cox

Patrick Cox

Patrick Cox has lived deep inside transformative technologies for over 25 years. In the 1980s, he worked in software development and manufacturing. By the mid-‘90s, he consulted for Netscape–which handled 90% of all Internet browsing traffic at the time. InfoWorld and USA Today have featured his research, and he’s written for The Wall Street Journal, Los Angeles Times, USA Today and Reason Magazine. Patrick has appeared on Crossfire and Nightline, and been written up in The Baltimore Sun and CNBC Magazine. Now, Patrick edits Breakthrough Technology Alert and Technology Profits Confidential, uncovering transformational technologies that offer exponential gains.

  1. Breakthrough Technology Alert

    Flash Sell: Time To Collect A 100% Gain… • May 11, 2012

    I just got off the phone with Patrick and he asked me to pop you a quick note… If you have been watching your portfolio today you can see that Arena Pharmaceuticals (NASDAQ: ARNA) has shot up 70% in response to FDA panel support of the company’s obesity drug. This puts us around a 100% gain. …Read more…

  2. Daily Reckoning

    An Electrifying Biotechnology – A Shot at Shocking Profits • May 9, 2012

    Fascination with the effects of electricity on the body goes back — way back. In the 1770s Italian physician and physicist Luigi Galvani shocked the world with the discovery that a spark could cause a dead frog’s legs to twitch. In 1802, German chemist Johann Wilhelm Ritter furthered Galvani’s research into electrophysiology. He observed how …Read more…

  3. Breakthrough Technology Alert

    NanoViricides Patent Award Creates Nano-Giant, Star Scientific Animal Study Reverses MS • May 8, 2012

    “There’s never been any real doubt that NanoViricides Inc. (OTCBB:NNVC) would be awarded the patent for the “virus killer” technology that gave the company its name. The technology is utterly novel. What we didn’t know, until now, is how broad the scope of the patent would be. With the notification of a patent award from the U.S. Patent and Trademark Office, to be issued today, NanoViricides Inc. has become the owner of an entire new field of science — the use of polymers for drug delivery far, far beyond the field of viruses. In a word, the scope of this patent award is gigantic.”…Read more…

  4. Breakthrough Technology Alert

    Star Scientific Story Continues to Build and a BioTime Update • May 1, 2012

    I’ve just returned from the Roskamp Institute, where my colleague Ray Blanco and I heard the latest regarding research into anatabine citrate, the active ingredient in the inflammation-controlling nutraceutical Anatabloc. As you know, this is the product discovered and developed by Star Scientific (CIGX: NASDAQ). There’s so much happening on the anatabine citrate front, it’s overwhelming. Between the researchers at Star Scientific and those at Johns Hopkins, the progress is head spinning. Unfortunately, scientists conducting studies cannot make public statements regarding their research prior to completion. I’m not free to talk about preliminary data on uncompleted studies.…Read more…

  5. Daily Reckoning

    Catastrophically Successful Life Extension • April 30, 2012

    Truly historic discoveries and therapies are coming online right now that will radically decrease the threat and cost of autoimmune disorders, cancers, cardiovascular disease, Alzheimer’s, arthritis, obesity and diabetes, as well as dangerous influenzas, HIV and other virus-borne diseases. Regular readers know that I’m referring to companies in our portfolio. Clearly, this is good news …Read more…

  6. Breakthrough Technology Alert

    Big Wins for BioTime and OncoSec • April 24, 2012

    A couple of years ago, short attackers were savaging one of my favorite companies, NanoViricides (OTCBB: NNVC). Not only was the company being accused of all manner of fraud, I was accused of being part of a conspiracy. Today, NanoViricides is in a far different position. The company has met with the FDA, and preparations are under way for clinical testing of FluCide, the nanobiotech influenza killer. Once testing has validated these submicroscopic polymer virus traps’ ability to take out influenza, it will be clear to everyone that the platform can be deployed against any and all viruses — from HIV and herpes to dengue, hepatitis, measles and rabies.…Read more…

  7. Penny Sleuth

    An Electrifying Biotechnology – A Shot at Shocking Profits • April 20, 2012

    Fascination with the effects of electricity on the body goes back — way back. In the 1770s Italian physician and physicist Luigi Galvani shocked the world with the discovery that a spark could cause a dead frog’s legs to twitch. In 1802, German chemist Johann Wilhelm Ritter furthered Galvani’s research into electrophysiology. He observed how …Read more…